Join A/Prof Peter Foley, Dr Lena Ly and Dr Francis Lai in an exploration of traditional systemic treatments and recent advanced targeted therapy additions for management of atopic dermatitis, including dupilumab, baricitinib and upadacitinib. Then, look into the future with a discussion on new agents on the horizon: abrocitinib, tralokinumab, and then some.